|
US7276497B2
(en)
*
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
CN101098854B
(zh)
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
CA3000520C
(en)
|
2005-08-24 |
2023-04-04 |
Immunogen, Inc. |
Process for preparing antibody maytansinoid conjugates
|
|
AU2008224988A1
(en)
|
2007-03-14 |
2008-09-18 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
CN101679974B
(zh)
|
2007-03-27 |
2015-09-30 |
航道生物技术有限责任公司 |
包含抗体替代轻链序列的构建体和文库
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
NZ610239A
(en)
|
2008-04-30 |
2014-11-28 |
Immunogen Inc |
Cross-linkers and their uses
|
|
SG189817A1
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Potent conjugates and hydrophilic linkers
|
|
CA2761681A1
(en)
|
2009-05-13 |
2010-11-18 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to influenza viruses
|
|
SG10201810743WA
(en)
|
2009-06-03 |
2018-12-28 |
Immunogen Inc |
Conjugation methods
|
|
AU2015201534B2
(en)
*
|
2009-06-03 |
2016-11-24 |
Immunogen, Inc. |
Conjugation methods
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
FR2949469A1
(fr)
*
|
2009-08-25 |
2011-03-04 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application en therapeutique
|
|
JP2013504585A
(ja)
*
|
2009-09-09 |
2013-02-07 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
TW201117814A
(en)
*
|
2009-10-02 |
2011-06-01 |
Sanofi Aventis |
New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
|
|
CN102596922A
(zh)
*
|
2009-10-06 |
2012-07-18 |
免疫基因公司 |
有效的缀合物和亲水性连接体
|
|
TWI622402B
(zh)
|
2010-02-24 |
2018-05-01 |
免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
SG10201501803YA
(en)
|
2010-03-12 |
2015-05-28 |
Immunogen Inc |
Cd37-binding molecules and immunoconjugates thereof
|
|
FR2963007B1
(fr)
|
2010-07-26 |
2013-04-05 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application therapeutique
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
EA201390472A1
(ru)
|
2010-10-29 |
2014-02-28 |
Иммьюноджен, Инк. |
Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты
|
|
EA201390575A1
(ru)
|
2010-10-29 |
2014-01-30 |
Иммьюноджен, Инк. |
Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты
|
|
AU2011323316B2
(en)
*
|
2010-11-03 |
2016-02-25 |
Immunogen, Inc. |
Cytotoxic agents comprising new ansamitocin derivatives
|
|
US20120121615A1
(en)
*
|
2010-11-17 |
2012-05-17 |
Flygare John A |
Alaninyl maytansinol antibody conjugates
|
|
LT3153504T
(lt)
|
2010-12-09 |
2019-02-11 |
Immunogen, Inc. |
Įkrautų skersinių jungčių agentų gavimo būdas
|
|
JP5826863B2
(ja)
|
2011-02-15 |
2015-12-02 |
イミュノジェン・インコーポレーテッド |
細胞傷害性ベンゾジアゼピン誘導体
|
|
US20140079722A1
(en)
*
|
2011-03-09 |
2014-03-20 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
MY171008A
(en)
|
2011-03-29 |
2019-09-23 |
Immunogen Inc |
Preparation of maytansinoid antibody conjugates by a one-step process
|
|
ME03353B
(me)
|
2011-03-29 |
2019-10-20 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
BR112013025415B1
(pt)
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
WO2012138749A1
(en)
*
|
2011-04-04 |
2012-10-11 |
Immunogen, Inc. |
Methods for decreasing ocular toxicity of antibody drug conjugates
|
|
HUE038848T2
(hu)
|
2011-04-21 |
2018-11-28 |
Bristol Myers Squibb Co |
CD40-antagonista antitest polipeptidek
|
|
WO2012171020A1
(en)
|
2011-06-10 |
2012-12-13 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EP2736928B1
(en)
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Sur-binding proteins against erbb3
|
|
CA2856411A1
(en)
|
2011-11-21 |
2013-05-30 |
Immunogen, Inc. |
Method of treatment of tumors that are resistant to egfr therapies by egfr antibody cytotoxic agent conjugate
|
|
US9975956B2
(en)
|
2011-12-22 |
2018-05-22 |
I2 Pharmaceuticals, Inc. |
Surrogate binding proteins which bind DR4 and/or DR5
|
|
EP2806898B1
(en)
*
|
2012-01-27 |
2018-07-18 |
F.Hoffmann-La Roche Ag |
Integrin antagonist conjugates for targeted delivery to cells expressing vla-4
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
US9200073B2
(en)
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
RU2661083C2
(ru)
|
2012-10-04 |
2018-07-11 |
Иммуноджен, Инк. |
Использование пвдф-мембраны для очистки конъюгатов клеточно-связывающий агент - цитотоксический агент
|
|
WO2014055842A1
(en)
*
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
BR112015008365A2
(pt)
|
2012-10-16 |
2017-07-04 |
Endocyte Inc |
composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente
|
|
NO2789793T3
(https=)
|
2012-10-24 |
2018-01-27 |
|
|
|
US20150290342A1
(en)
*
|
2012-10-24 |
2015-10-15 |
Polytherics Limited |
Drug-protein conjugates
|
|
CA2891280C
(en)
|
2012-11-24 |
2018-03-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
CN104530235A
(zh)
|
2012-12-21 |
2015-04-22 |
百奥泰生物科技(广州)有限公司 |
一种抑制肿瘤生长的抗体药物衍生物及其制备方法和用途
|
|
CN104688740A
(zh)
*
|
2012-12-21 |
2015-06-10 |
百奥泰生物科技(广州)有限公司 |
类美登素衍生物及其制备方法和用途
|
|
US9968673B2
(en)
*
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
|
FR3002454B1
(fr)
*
|
2013-02-26 |
2015-04-10 |
Commissariat Energie Atomique |
Composition immunogene sous forme d'emulsion
|
|
EP3566750A3
(en)
*
|
2013-02-28 |
2020-04-08 |
ImmunoGen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
HK1220626A1
(zh)
|
2013-03-15 |
2017-05-12 |
The Centre For Drug Research And Development |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
JP6847388B2
(ja)
|
2013-03-15 |
2021-03-31 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
生物活性分子、そのコンジュゲート、及び治療用途
|
|
BR112015027474A8
(pt)
*
|
2013-05-02 |
2018-01-23 |
Hoffmann La Roche |
anticorpo, composição, método de tratamento do paciente que sofre de câncer e uso de um anticorpo.
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
BR112016004023A2
(pt)
|
2013-08-26 |
2022-11-16 |
Regeneron Pharma |
Composição, métodos para preparar uma composição e para tratar uma doença, e, composto
|
|
CN113150145B
(zh)
|
2013-08-30 |
2025-02-14 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
WO2015035108A1
(en)
|
2013-09-05 |
2015-03-12 |
The Jackson Laboratory |
Compositions for rna-chromatin interaction analysis and uses thereof
|
|
PL3055332T3
(pl)
|
2013-10-08 |
2020-02-28 |
Immunogen, Inc. |
Schematy dawkowania immunokoniugatu anty-FOLR1
|
|
ES2754397T3
(es)
|
2013-10-11 |
2020-04-17 |
Asana Biosciences Llc |
Conjugados de proteína-polímero-fármaco
|
|
KR102087850B1
(ko)
|
2013-10-11 |
2020-03-12 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-고분자-약물 접합체
|
|
CN103483357B
(zh)
*
|
2013-10-12 |
2015-11-18 |
齐鲁制药有限公司 |
一种抗体-美登素偶联物的中间体新晶型及其制备方法
|
|
US9562059B2
(en)
*
|
2013-12-02 |
2017-02-07 |
Hong Kong Baptist University |
Anticancer maytansinoids with two fused macrocyclic rings
|
|
WO2015095953A1
(en)
|
2013-12-27 |
2015-07-02 |
The Centre For Drug Research And Development |
Sulfonamide-containing linkage systems for drug conjugates
|
|
US10562977B2
(en)
*
|
2014-01-29 |
2020-02-18 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof
|
|
JP6632984B2
(ja)
|
2014-03-11 |
2020-01-22 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
抗ＥＧＦＲｖＩＩＩ抗体およびその使用
|
|
MA39774A
(fr)
*
|
2014-03-24 |
2021-05-12 |
Roche Sequencing Solutions Inc |
Procédés chimiques pour produire des nucléotides étiquetés
|
|
JP6666264B2
(ja)
*
|
2014-04-29 |
2020-03-13 |
ジーンクアンタム ヘルスケア （スーチョウ） シーオー．， エルティーディー．Ｇｅｎｅｑｕａｎｔｕｍ Ｈｅａｌｔｈｃａｒｅ （Ｓｕｚｈｏｕ）Ｃｏ．， Ｌｔｄ． |
新規安定型抗体薬物複合体の作製およびその応用
|
|
MX379365B
(es)
|
2014-06-30 |
2025-03-11 |
Tarveda Therapeutics Inc |
Conjugados y partículas direccionados y formulaciones de estos.
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
SG11201701328XA
(en)
|
2014-09-02 |
2017-03-30 |
Immunogen Inc |
Methods for formulating antibody drug conjugate compositions
|
|
KR102508023B1
(ko)
*
|
2014-09-03 |
2023-03-10 |
이뮤노젠 아이엔씨 |
세포-결합제 및 세포독성 약물을 포함하는 콘주게이트
|
|
AU2015311987B2
(en)
|
2014-09-03 |
2020-06-04 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
WO2016036804A1
(en)
|
2014-09-03 |
2016-03-10 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
ES2905569T3
(es)
|
2014-09-17 |
2022-04-11 |
Zymeworks Inc |
Compuestos citotóxicos y antimitóticos y métodos para utilizarlos
|
|
BR112017020149A8
(pt)
|
2015-03-27 |
2023-05-02 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados dos mesmos e métodos de uso
|
|
IL292798A
(en)
|
2015-05-04 |
2022-07-01 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, preparations containing them and their uses
|
|
CN106243127B
(zh)
*
|
2015-06-09 |
2021-01-26 |
凯惠科技发展(上海)有限公司 |
抗体药物偶联物、中间体、制备方法、药物组合物及应用
|
|
SMT202000614T1
(it)
|
2015-06-29 |
2021-01-05 |
Immunogen Inc |
Coniugati di anticorpi ingegnerizzati con cisteina
|
|
EP3317246A4
(en)
*
|
2015-07-04 |
2019-02-27 |
Suzhou M-conj Biotech Co., Ltd. |
SPECIFIC CONJUGATION OF A CELL BINDING MOLECULE
|
|
IL296285A
(en)
|
2015-07-06 |
2022-11-01 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
EP3325482B1
(en)
|
2015-07-21 |
2020-06-24 |
ImmunoGen, Inc. |
Methods of preparing cytotoxic benzodiazepine derivatives
|
|
US10509035B2
(en)
|
2015-08-07 |
2019-12-17 |
Gamamabs Pharma Sa |
Antibodies, antibody drug conjugates and methods of use
|
|
CN116440279B
(zh)
|
2015-09-17 |
2026-02-24 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|
|
US11160871B2
(en)
|
2015-10-28 |
2021-11-02 |
Tarveda Therapeutics, Inc. |
SSTR-targeted conjugates and particles and formulations thereof
|
|
EP3373910B1
(en)
|
2015-11-10 |
2023-07-12 |
Children's Research Institute, Children's National Medical Center |
Echinomycin formulation, method of making and method of use thereof
|
|
US20170189548A1
(en)
|
2015-11-25 |
2017-07-06 |
Immunogen, Inc. |
Pharmaceutical formulations and methods of use thereof
|
|
MA43416A
(fr)
|
2015-12-11 |
2018-10-17 |
Regeneron Pharma |
Méthodes pour ralentir ou empêcher la croissance de tumeurs résistantes au blocage de l'egfr et/ou d'erbb3
|
|
BR112018014759B1
(pt)
|
2016-01-25 |
2024-02-27 |
Regeneron Pharmaceuticals, Inc |
Compostos derivados de maitasinoide e seus conjugados, composição compreendendo os mesmos, seus métodos de fabricação e uso
|
|
PE20231050A1
(es)
*
|
2016-03-02 |
2023-07-11 |
Eisai Randd Man Co Ltd |
Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
|
|
JP6937773B2
(ja)
*
|
2016-03-07 |
2021-09-22 |
ハンミ ファーマシューティカル カンパニー リミテッド |
ポリエチレングリコール誘導体及びその用途
|
|
EP3448891A1
(en)
|
2016-04-28 |
2019-03-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
|
WO2017197045A1
(en)
|
2016-05-11 |
2017-11-16 |
Movassaghi Mohammad |
Convergent and enantioselective total synthesis of communesin analogs
|
|
AU2017279550A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-B7-H3 antibodies and antibody drug conjugates
|
|
EP3478324A1
(en)
|
2016-07-01 |
2019-05-08 |
GlaxoSmithKline Intellectual Property (No.2) Limited |
Antibody-drug conjugates and therapeutic methods using the same
|
|
RU2653443C2
(ru)
*
|
2016-07-15 |
2018-05-08 |
Закрытое Акционерное Общество "Биокад" |
Биспецифичные анти-her2/анти-her3 антитела
|
|
JP7066690B2
(ja)
|
2016-09-23 |
2022-05-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗ｍｕｃ１６（ムチン１６）抗体
|
|
MY199468A
(en)
|
2016-09-23 |
2023-10-31 |
Regeneron Pharma |
Anti-steap2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind steap2 and cd3, and uses thereof
|
|
ES3046537T3
(en)
|
2016-11-08 |
2025-12-02 |
Regeneron Pharma |
Steroids and protein-conjugates thereof
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
WO2018098258A2
(en)
|
2016-11-23 |
2018-05-31 |
Immunogen, Inc. |
Selective sulfonation of benzodiazepine derivatives
|
|
EP3548514A1
(en)
|
2016-11-29 |
2019-10-09 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating prlr positive breast cancer
|
|
EP3554544A4
(en)
|
2016-12-16 |
2020-07-29 |
Bluefin Biomedicine, Inc. |
ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
|
|
PL3558391T3
(pl)
|
2016-12-23 |
2022-05-16 |
Immunogen, Inc. |
Immunokoniugaty skierowane wobec białka adam9 i sposoby ich stosowania
|
|
US20180230218A1
(en)
|
2017-01-04 |
2018-08-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
TWI781145B
(zh)
|
2017-02-28 |
2022-10-21 |
美商伊繆諾金公司 |
具有自分解肽連接子之類美登素衍生物及其結合物
|
|
CN117982673A
(zh)
|
2017-02-28 |
2024-05-07 |
第一三共株式会社 |
抗her3抗体-药物偶联物的应用
|
|
EP3381474A1
(en)
*
|
2017-03-27 |
2018-10-03 |
Alfasigma S.p.A. |
Histone deacetylase inhibitors-based antibody drug conjugates (adcs) and use in therapy
|
|
EP3604385B1
(en)
*
|
2017-03-30 |
2024-05-01 |
NOF Corporation |
Heterobifunctional monodispersed polyethylene glycol and conjugate using the same
|
|
WO2018195243A1
(en)
|
2017-04-20 |
2018-10-25 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and conjugates thereof
|
|
US11932650B2
(en)
|
2017-05-11 |
2024-03-19 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
KR20200007905A
(ko)
|
2017-05-18 |
2020-01-22 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
WO2018213082A1
(en)
|
2017-05-18 |
2018-11-22 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
DK3635009T3
(da)
|
2017-06-07 |
2026-03-30 |
Regeneron Pharma |
Sammensætninger og fremgangsmåder til internalisering af enzymer
|
|
EP3641831B1
(en)
*
|
2017-06-20 |
2024-11-06 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
CN109771658B
(zh)
*
|
2017-11-14 |
2021-12-10 |
博瑞生物医药（苏州）股份有限公司 |
靶向多臂偶联物
|
|
US11793885B2
(en)
|
2017-12-28 |
2023-10-24 |
Immunogen, Inc. |
Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders
|
|
SG11202006510XA
(en)
|
2018-01-08 |
2020-08-28 |
Regeneron Pharma |
Steroids and antibody-conjugates thereof
|
|
US11274121B2
(en)
*
|
2018-01-12 |
2022-03-15 |
Immunogen, Inc. |
Methods for antibody drug conjugation, purification, and formulation
|
|
KR102871690B1
(ko)
|
2018-04-30 |
2025-10-16 |
리제너론 파마슈티칼스 인코포레이티드 |
Her2 및/또는 aplp2에 결합하는 항체 및 이중특이적 항원-결합 분자 및 접합체 그리고 이들의 용도
|
|
CN118955710A
(zh)
|
2018-05-09 |
2024-11-15 |
里珍纳龙药品有限公司 |
抗msr1抗体及其使用方法
|
|
BR112020023145A2
(pt)
|
2018-05-17 |
2021-02-02 |
Regeneron Pharmaceuticals, Inc. |
anticorpo anti-cd63 ou fragmento de ligação ao antígeno do mesmo, molécula de ligação ao antígeno biespecífica, proteína terapêutica de múltiplos domínios, polinucleotídeo composição farmacêutica, e, composto
|
|
MX2020013466A
(es)
|
2018-06-26 |
2021-04-19 |
Immunogen Inc |
Inmunoconjugados dirigidos a adam9 y métodos para usarlos.
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
WO2020059772A1
(ja)
|
2018-09-20 |
2020-03-26 |
第一三共株式会社 |
抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｈｅｒ３変異がんの治療
|
|
CN109350748B
(zh)
*
|
2018-10-24 |
2021-06-11 |
沈阳药科大学 |
氧化还原双敏感键桥连小分子前药及其自组装纳米粒
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
IL283313B2
(en)
|
2018-11-20 |
2025-08-01 |
Regeneron Pharma |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
PH12021551476A1
(en)
|
2018-12-21 |
2022-04-25 |
Regeneron Pharma |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
JP7590328B2
(ja)
|
2018-12-21 |
2024-11-26 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
ツブリシン及びタンパク質－ツブリシンコンジュゲート
|
|
BR112021013464A2
(pt)
|
2019-01-08 |
2021-09-21 |
Regeneron Pharmaceuticals, Inc. |
Ligantes sem traço e conjugados de proteína dos mesmos
|
|
CA3128519A1
(en)
|
2019-02-21 |
2020-08-27 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met
|
|
DK3941946T3
(da)
|
2019-03-20 |
2025-03-24 |
Univ California |
Claudin-6-antistoffer og lægemiddelkonjugater
|
|
US20220177583A1
(en)
|
2019-03-20 |
2022-06-09 |
The Regents Of The University Of California |
Claudin-6 bispecific antibodies
|
|
CN113661172A
(zh)
|
2019-03-29 |
2021-11-16 |
伊缪诺金公司 |
用于抑制异常细胞生长或治疗增生性疾病的细胞毒性双苯并二氮杂䓬衍生物及其与细胞结合剂的缀合物
|
|
SG11202110922QA
(en)
|
2019-04-26 |
2021-10-28 |
Immunogen Inc |
Camptothecin derivatives
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
US11555019B2
(en)
|
2019-07-10 |
2023-01-17 |
Cybrexa 3, Inc. |
Peptide conjugates of microtubule-targeting agents as therapeutics
|
|
MX2022000449A
(es)
|
2019-07-10 |
2022-04-25 |
Cybrexa 2 Inc |
Conjugados peptídicos de citotoxinas como terapéuticos.
|
|
AU2020349462A1
(en)
|
2019-09-16 |
2022-03-03 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled MET binding proteins for immuno-PET imaging
|
|
US11814428B2
(en)
|
2019-09-19 |
2023-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-PTCRA antibody-drug conjugates and uses thereof
|
|
JP2023511956A
(ja)
|
2020-01-24 |
2023-03-23 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
タンパク質－抗ウイルス化合物コンジュゲート
|
|
WO2021173773A1
(en)
|
2020-02-25 |
2021-09-02 |
Mediboston, Inc. |
Camptothecin derivatives and conjugates thereof
|
|
KR20220148200A
(ko)
|
2020-02-28 |
2022-11-04 |
리제너론 파마슈티칼스 인코포레이티드 |
Her2에 결합하는 이중특이적 항원 결합 분자 및 이의 사용 방법
|
|
CN115968304A
(zh)
|
2020-04-16 |
2023-04-14 |
瑞泽恩制药公司 |
狄尔斯-阿尔德缀合方法
|
|
WO2021262910A2
(en)
|
2020-06-24 |
2021-12-30 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
WO2022010797A2
(en)
|
2020-07-07 |
2022-01-13 |
Bionecure Therapeutics, Inc. |
Novel maytansinoids as adc payloads and their use for the treatment of cancer
|
|
CN116390771A
(zh)
|
2020-07-13 |
2023-07-04 |
瑞泽恩制药公司 |
与蛋白中的谷氨酰胺残基缀合的喜树碱类似物及其用途
|
|
IL299803A
(en)
|
2020-07-17 |
2023-03-01 |
Daiichi Sankyo Co Ltd |
Production method for antibody-drug conjugate
|
|
CA3191304A1
(en)
|
2020-09-14 |
2022-03-17 |
Amy Han |
Antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof
|
|
CA3190569A1
(en)
|
2020-10-22 |
2022-04-28 |
Christopher Daly |
Anti-fgfr2 antibodies and methods of use thereof
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
WO2022182415A1
(en)
|
2021-02-24 |
2022-09-01 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US12521444B2
(en)
|
2021-02-25 |
2026-01-13 |
Fortvita Biologics Limited |
Anti-HER2 antibody-drug conjugates and uses thereof
|
|
KR102917231B1
(ko)
|
2021-03-08 |
2026-01-26 |
진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. |
항체 면역 작용제 접합체 및 이의 적용
|
|
CN117177775A
(zh)
|
2021-04-14 |
2023-12-05 |
启德医药科技（苏州）有限公司 |
连接子、缀合物及其应用
|
|
CA3220081A1
(en)
|
2021-07-28 |
2023-02-02 |
Thomas Nittoli |
Protein-antiviral compound conjugates
|
|
EP4389804A4
(en)
*
|
2021-08-20 |
2025-10-08 |
Nat Univ Pusan Ind Univ Coop Found |
PROCESS FOR PREPARING A SWELLABLE POLYMER TO WHICH AN OBJECT IS ATTACHED
|
|
JP2024546948A
(ja)
*
|
2021-12-15 |
2024-12-26 |
ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド |
コンジュゲート、それらの組成物、及びそれらの関連する方法
|
|
US20230414775A1
(en)
|
2021-12-29 |
2023-12-28 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
CA3241734A1
(en)
|
2022-01-12 |
2023-07-20 |
Amy Han |
Camptothecin analogs conjugated to a glutamine residue in a protein, and their use
|
|
AU2023208050A1
(en)
|
2022-01-14 |
2024-07-04 |
Regeneron Pharmaceuticals, Inc. |
Verrucarin a derivatives and antibody drug conjugates thereof
|
|
JP2025512735A
(ja)
|
2022-03-11 |
2025-04-22 |
リジェネロン ファーマシューティカルズ，インク． |
Ｇｌｐ１ペプチド模倣体を含む抗ｇｌｐ１ｒ抗体係留型薬物コンジュゲートおよびその使用
|
|
CN120239705A
(zh)
|
2022-07-21 |
2025-07-01 |
萤火虫生物股份有限公司 |
糖皮质激素受体激动剂和其缀合物
|
|
TW202412762A
(zh)
|
2022-07-27 |
2024-04-01 |
香港商祐方有限公司 |
奧瑞他汀衍生物及其結合物
|
|
WO2024118785A2
(en)
|
2022-11-30 |
2024-06-06 |
Regeneron Pharmaceuticals, Inc. |
Tlr7 agonists and antibody-drug-conjugates thereof
|
|
WO2024138000A1
(en)
|
2022-12-21 |
2024-06-27 |
Regeneron Pharmaceuticals, Inc. |
Prodrugs of topoisomerase i inhibitor for adc conjugations and methods of use thereof
|
|
WO2024168199A1
(en)
|
2023-02-09 |
2024-08-15 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates via inverse electron demand diels-alder reactions
|
|
WO2024220628A1
(en)
*
|
2023-04-18 |
2024-10-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Target for combatting the foreign body response to implantable biomaterials
|
|
WO2024229105A1
(en)
|
2023-05-02 |
2024-11-07 |
Regeneron Pharmaceuticals, Inc. |
Anti-human m-cadherin (cdh15) antibodies, conjugates, and uses thereof for delivery of genetic payloads to muscle cells
|
|
EP4721766A1
(en)
|
2023-06-02 |
2026-04-08 |
Daiichi Sankyo Company, Limited |
Combination of (anti-her3 antibody)-drug conjugate and rasg12c inhibitor
|
|
CN121568720A
(zh)
|
2023-07-10 |
2026-02-24 |
瑞泽恩制药公司 |
抗人类cacng1抗体-药物缀合物及其用途
|
|
WO2025094146A1
(en)
|
2023-11-02 |
2025-05-08 |
Immunogen Switzerland Gmbh |
Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
|
|
US20250171516A1
(en)
|
2023-11-03 |
2025-05-29 |
Regeneron Pharmaceuticals, Inc. |
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof
|
|
WO2025117727A1
(en)
|
2023-11-29 |
2025-06-05 |
Regeneron Pharmaceuticals, Inc. |
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof
|
|
CN118580194A
(zh)
*
|
2024-05-21 |
2024-09-03 |
南方科技大学 |
一种双功能分子探针的制备方法
|
|
US20260078179A1
(en)
|
2024-07-18 |
2026-03-19 |
Novarock Biotherapeutics, Ltd. |
Cdh17 antibodies and uses thereof
|
|
WO2026021443A1
(en)
|
2024-07-23 |
2026-01-29 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Antibody-drug conjugates targeting cdh3 and preparation methods and uses thereof
|